Back
IDACORP, Inc. 10K Form
Buy
75
IDA
IDACORP, Inc.
Last Price:
$139.84
Seasonality Move:
-0.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | IDA/IDACORP, Inc. Quarterly |
| 2023-11-02 | 10Q | IDA/IDACORP, Inc. Quarterly |
| 2023-08-03 | 10Q | IDA/IDACORP, Inc. Quarterly |
| 2023-05-04 | 10Q | IDA/IDACORP, Inc. Quarterly |
| 2022-11-03 | 10Q | IDA/IDACORP, Inc. Quarterly |
| 2022-08-04 | 10Q | IDA/IDACORP, Inc. Quarterly |
Receive IDA News And Ratings
See the #1 stock for the next 7 days that we like better than IDA
IDA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.8B |
|---|---|
| Cash Flow: | $-232.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $65.11 |
| Price / Book: | 2.12 |
Profitability
| EPS (TTM): | 5.90750 |
|---|---|
| Net Income (TTM): | $324.1M |
| Gross Margin: | $401.4M |
| Return on Equity: | 9.44% |
| Return on Assets: | 3.26% |
IDACORP, Inc. Earnings Forecast
Key IDACORP, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for IDA is 22.16%.
-
The Selling, General & Administrative Expenses for IDA have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 51.89% of Operating Income.
-
The Net Earning history of IDA is 17.89% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 28 years.
IDACORP, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | IDA |
| CUSIP: | 451107 |
| Website: | idacorpinc.com |
Debt
| Debt-to-Equity Ratio: | 1.03 |
|---|---|
| Current Ratio: | 0.93 |
| Quick Ratio: | 0.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.7 |
|---|---|
| Forward P/E Ratio: | 20.28 |
IDA Technical Analysis vs Fundamental Analysis
Buy
75
IDACORP, Inc. (IDA)
is a Buy
Is IDACORP, Inc. a Buy or a Sell?
-
IDACORP, Inc. stock is rated a BuyThe current IDACORP, Inc. [IDA] share price is $139.89. The Score for IDA is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.